For FY25, monday.com has raised its full-year guidance outlook to $1.22-$1.226 billion in revenue, representing a 25-26% y/y ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

Learn why market extremes create opportunities and how to invest smartly despite risks. See here for two deep-value stocks ...

AI workload demands continue to expand, with generative AI a driver of further investment in infrastructure. As organizations ...

Amazon's balance sheet is one of the strongest on the planet, boasting an AA credit rating from S&P on a stable outlook. Read ...

Macy’s faces core sales pressure and leadership uncertainty despite luxury strength, dimming its near-term outlook and ...

Kanzhun posted strong Q1 results with solid user growth, but macro risks in China cloud the outlook despite AI tailwinds.

The U.S. stocks in May recorded their best monthly advance since November 2023 recovering from tariff overhang. Read more ...

Zeta's growth and AI adoption signal strong future prospects despite past challenges. Read here to know why we recommend a ...

Sweetgreen navigates slowing consumer spending with menu innovation, rewards, and expansion plans, while still facing macro headwinds. Read why SG stock is not as lucrative.

TELUS posted strong Q1'25 results, raised its dividend, and continues to lead in telecom growth with standout segments and ...

Aflac is achieving strong returns via earnings growth and buybacks, despite revenue challenges. Click to read why AFL stock ...